Silence Therapeutics SLN
NASDAQ SLN
$19.79 +0.04 (+0.20%)
At close: Nov 10, 2026 · 4:00 PM EST

Silence Therapeutics (SLN) Long-Term Deferred Tax (2018 - 2020)

Updated

Silence Therapeutics (SLN) posted Long-Term Deferred Tax of $33,011 for the quarter ended Dec 31, 2020, up 7.0% from $30,857 a year earlier.

Analysis

Silence Therapeutics (SLN) Long-Term Deferred Tax (2018 - 2020) Analysis & Trends

As of Dec 31, 2020, Silence Therapeutics' Long-Term Deferred Tax came in at $32,104, up 4.8% from the prior year.

  • In prior years, Silence Therapeutics' Long-Term Deferred Tax was $30,644 in the year ended Dec 31, 2019 (+76.5%) and $17,362 in the year ended Dec 31, 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Silence Therapeutics 932.92 Mn 860.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 34,076.66
Dec 31, 2019 31,471.28
Dec 31, 2018 16,501.65
API Access

Silence Therapeutics Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=SLN&period=max&api_key=YOUR_API_KEY